Adaptimmune Therapeutics Plc (ADAPY)
0.0329
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Adaptimmune Therapeutics Total Liabilities (Quarterly) : 201.59M for June 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | 201.59M |
| March 31, 2025 | 195.50M |
| December 31, 2024 | 234.11M |
| September 30, 2024 | 237.45M |
| June 30, 2024 | 225.43M |
| March 31, 2024 | 233.64M |
| December 31, 2023 | 243.10M |
| September 30, 2023 | 208.51M |
| June 30, 2023 | 216.33M |
| March 31, 2023 | 204.20M |
| December 31, 2022 | 247.04M |
| September 30, 2022 | 218.86M |
| June 30, 2022 | 246.35M |
| March 31, 2022 | 256.65M |
| December 31, 2021 | 263.58M |
| September 30, 2021 | 112.54M |
| June 30, 2021 | 111.85M |
| March 31, 2021 | 102.42M |
| December 31, 2020 | 109.92M |
| Date | Value |
|---|---|
| September 30, 2020 | 102.82M |
| June 30, 2020 | 104.62M |
| March 31, 2020 | 99.20M |
| December 31, 2019 | 57.90M |
| September 30, 2019 | 60.57M |
| June 30, 2019 | 52.53M |
| March 31, 2019 | 50.78M |
| December 31, 2018 | 29.85M |
| September 30, 2018 | 33.47M |
| June 30, 2018 | 46.20M |
| March 31, 2018 | 55.81M |
| December 31, 2017 | 78.16M |
| September 30, 2017 | 72.39M |
| June 30, 2017 | 54.78M |
| March 31, 2017 | 57.65M |
| December 31, 2016 | 68.37M |
| September 30, 2016 | 42.64M |
| June 30, 2016 | 42.57M |
| March 31, 2016 | 42.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Kiniksa Pharmaceuticals International Plc | 219.59M |
| Autolus Therapeutics Plc | 418.24M |
| Aptorum Group Ltd. | 4.900M |
| Bicycle Therapeutics Plc | 98.08M |
| Barinthus Biotherapeutics Plc | 25.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 130.63M |
| Shareholders Equity (Quarterly) | -70.96M |